Oslo, 24 October 2019: Observe Medical ASA (the “Company”) today announces that Björn Larsson is appointed Chief Executive Officer of the Company effective mid-December 2019. Mr. Larsson succeeds Ole Henrik Eriksen who has held the position as interim CEO of
Navamedic ASA announces the finalisation of the Sippi® wireless connectivity solution to Patient Data Monitoring Systems (PDMS). The company has appointed a renowned adviser for the process of maximising the value of Sippi® and is evaluating several strategic alternatives for
Oslo, May 31, 2017 – Navamedic ASA (OSE: NAVA) announced today that it has been granted a patent by the European Patent Office for the base technology of Sippi®, using capacitance as a volume measurement in urine handling systems. “We
Reference is made to the stock exchange announcement of 14 May 2019 regarding the proposed restructuring of Navamedic ASA (the “Company” or “NAVA” and together with its direct and indirect subsidiaries, the “NAVA group”), whereby the Company’s Medtech division is
Oslo, 14 May 2019 – The Board of Directors of Navamedic ASA (OSE: NAVA) has decided to propose for the Extraordinary General Assembly to separately list the Medtech division on the Oslo Stock Exchange in the third quarter of 2019.